Mark L Ormiston

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Transforming Growth Factor

Polycyclic Aromatic Hydrocarbons

Pulmonary Arterial Hypertension

Top Venues

Hypertension (Dallas, Tex. : 1979)

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Danchen Wu, Ross D Jansen-van Vuuren, Asish Dasgupta, Ruaa Al-Qazazi, Kuang-Hueih Chen, Ashley Y Martin, Jeffrey D Mewburn, Elahe Alizadeh, Patricia Daniele Azevedo Lima, Oliver Jones, Pierce Colpman, Rachel E T Bentley, M Martin VandenBroek, Nolan M Breault, Isaac M Emon, V Siddartha Yerramilli, Luka Jedlovčnik, Yuan Zhao, Michael Wells, Gopinath Sutendra, Mark L Ormiston, Stephen L Archer
Novel Drp1 GTPase Inhibitor, Drpitor1a: Efficacy in Pulmonary Hypertension. Hypertension (Dallas, Tex. : 1979) (2024)
Kassandra M Coyle, Lindsey G Hawke, Mark L Ormiston
Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics. Cancers 15 (6) (2023)
Kassandra M Coyle, Lindsey G Hawke, Mark L Ormiston
Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics. Cancers 15 (6) (2023)
Nicholas D Cober, M Martin VandenBroek, Mark L Ormiston, Duncan J Stewart
Evolving Concepts in Endothelial Pathobiology of Pulmonary Arterial Hypertension. Hypertension (Dallas, Tex. : 1979) 79 (8) (2022)
Lindsey G Hawke, Brandon Z Mitchell, Mark L Ormiston
TGF-β and IL-15 Synergize through MAPK Pathways to Drive the Conversion of Human NK Cells to an Innate Lymphoid Cell 1-like Phenotype. Journal of immunology (Baltimore, Md. : 1950) 204 (12) (2020)